{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:20:50Z","timestamp":1793924450165,"version":"4.8.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":592,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P30AG066506"],"award-info":[{"award-number":["P30AG066506"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P50AG047266"],"award-info":[{"award-number":["P50AG047266"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13311-021-01146-y","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:51:20Z","timestamp":1635861080000},"page":"173-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":368,"title":["Neuropathology of Alzheimer's Disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Jorge A.","family":"Trejo-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Yachnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-2149","authenticated-orcid":false,"given":"Stefan","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01146-y_bib1","unstructured":"A. A. \u00dcber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Psych-Gericht Med. 1907;64:146\u20138."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun."},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib3","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.83.11.4040","article-title":"Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)","volume":"83","author":"Wood","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib4","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1007\/s13311-021-01146-y_bib5","doi-asserted-by":"crossref","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261(13):6084\u20139.","DOI":"10.1016\/S0021-9258(17)38495-8"},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib6","first-page":"81","article-title":"Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2","volume":"126","author":"Yen","year":"1987","journal-title":"Am J Pathol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/oxfordjournals.jbchem.a135625","article-title":"One of the antigenic determinants of paired helical filaments is related to tau protein","volume":"99","author":"Nukina","year":"1986","journal-title":"J Biochem."},{"issue":"2\u20133","key":"10.1007\/s13311-021-01146-y_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(86)90167-X","article-title":"Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments","volume":"76","author":"Delacourte","year":"1986","journal-title":"J Neurol Sci."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnen\/nlab001","article-title":"The Second NINDS\/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy","volume":"80","author":"Bieniek","year":"2021","journal-title":"J Neuropathol Exp Neurol."},{"issue":"7","key":"10.1007\/s13311-021-01146-y_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnen\/nlx041","article-title":"Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG)","volume":"76","author":"Kovacs","year":"2017","journal-title":"J Neuropathol Exp Neurol."},{"issue":"6347","key":"10.1007\/s13311-021-01146-y_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/353844a0","article-title":"Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene","volume":"353","author":"Chartier-Harlin","year":"1991","journal-title":"Nature."},{"issue":"6311","key":"10.1007\/s13311-021-01146-y_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature."},{"issue":"6405","key":"10.1007\/s13311-021-01146-y_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature."},{"issue":"6543","key":"10.1007\/s13311-021-01146-y_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature."},{"issue":"6534","key":"10.1007\/s13311-021-01146-y_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature."},{"issue":"5226","key":"10.1007\/s13311-021-01146-y_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science."},{"issue":"5580","key":"10.1007\/s13311-021-01146-y_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science."},{"key":"10.1007\/s13311-021-01146-y_bib21","unstructured":"Walker LC. Abeta Plaques. Free Neuropathology. 2020."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","article-title":"Identification of normal and pathological aging in prospectively studied nondemented elderly humans","volume":"13","author":"Dickson","year":"1992","journal-title":"Neurobiol Aging."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1096-9861(19980713)396:4<511::AID-CNE7>3.0.CO;2-4","article-title":"Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease","volume":"396","author":"Styren","year":"1998","journal-title":"J Comp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03036452","article-title":"Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain","volume":"7","author":"Martin-Rehrmann","year":"2005","journal-title":"Neurotox Res."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/bbrc.1993.1406","article-title":"Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease","volume":"192","author":"Yasuhara","year":"1993","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer's Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib29","first-page":"564","article-title":"Amyloid angiopathy in Alzheimer's disease","volume":"14","author":"Bergeron","year":"1987","journal-title":"Can J Neurol Sci."},{"issue":"8","key":"10.1007\/s13311-021-01146-y_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1468-1331.2007.01880.x","article-title":"Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage","volume":"14","author":"Jellinger","year":"2007","journal-title":"Eur J Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.2002.tb00449.x","article-title":"Sporadic and familial cerebral amyloid angiopathies","volume":"12","author":"Revesz","year":"2002","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-4159.1988.tb01087.x","article-title":"Differences between vascular and plaque core amyloid in Alzheimer's disease","volume":"51","author":"Prelli","year":"1988","journal-title":"J Neurochem."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0006-8993(88)90673-7","article-title":"Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging","volume":"474","author":"Joachim","year":"1988","journal-title":"Brain Res."},{"key":"10.1007\/s13311-021-01146-y_bib34","doi-asserted-by":"crossref","unstructured":"Gravina SA, Ho L, Eckman CB, Long KE, Otvos L, Younkin LH, et al. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem. 1995;270(13):7013\u20136.","DOI":"10.1074\/jbc.270.13.7013"},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(98)00286-9","article-title":"High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage","volume":"247","author":"McCarron","year":"1998","journal-title":"Neurosci Lett."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-010-0707-9","article-title":"Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease","volume":"120","author":"Thal","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","article-title":"Two types of sporadic cerebral amyloid angiopathy","volume":"61","author":"Thal","year":"2002","journal-title":"J Neuropathol Exp Neurol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1007\/s13311-021-01146-y_bib43","doi-asserted-by":"crossref","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 Pathway in Alzheimer's Disease. Mol Psychiatry. 2021.","DOI":"10.1038\/s41380-021-01249-0"},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","article-title":"Correlation of amyloid PET ligand florbetapir F 18 binding with A\u03b2 aggregation and neuritic plaque deposition in postmortem brain tissue","volume":"26","author":"Choi","year":"2012","journal-title":"Alzheimer Dis Assoc Disord."},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib45","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archneurol.2011.535","article-title":"Positron emission tomography and neuropathologic estimates of fibrillar amyloid-\u03b2 in a patient with Down syndrome and Alzheimer disease","volume":"68","author":"Sabbagh","year":"2011","journal-title":"Arch Neurol."},{"issue":"8","key":"10.1007\/s13311-021-01146-y_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","article-title":"Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","volume":"72","author":"Curtis","year":"2015","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1007\/s13311-021-01146-y_bib48","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","article-title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"18","key":"10.1007\/s13311-021-01146-y_bib49","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer's Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-018-0424-5","article-title":"Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)","volume":"10","author":"Salloway","year":"2018","journal-title":"Alzheimers Res Ther."},{"issue":"7","key":"10.1007\/s13311-021-01146-y_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nat Med."},{"issue":"7618","key":"10.1007\/s13311-021-01146-y_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/nen.0b013e3181633526","article-title":"Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium","volume":"67","author":"Alafuzoff","year":"2008","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1007\/s13311-021-01146-y_bib56","doi-asserted-by":"crossref","unstructured":"Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med. 2012;2(7):a006247.","DOI":"10.1101\/cshperspect.a006247"},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib57","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bpa.12289","article-title":"Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology","volume":"26","author":"Stratmann","year":"2016","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/nan.12387","article-title":"Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease","volume":"43","author":"Ehrenberg","year":"2017","journal-title":"Neuropathol Appl Neurobiol."},{"key":"10.1007\/s13311-021-01146-y_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-981-32-9358-8_23","article-title":"Tau Prion-Like Propagation: State of the Art and Current Challenges","volume":"1184","author":"Dujardin","year":"2019","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-Gut-Microbiota Axis in Alzheimer's Disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"J Neurogastroenterol Motil."},{"key":"10.1007\/s13311-021-01146-y_bib62","doi-asserted-by":"crossref","unstructured":"Beach TG, Adler CH, Sue LI, Shill HA, Driver-Dunckley E, Mehta SH, et al. Vagus Nerve and Stomach Synucleinopathy in Parkinson Disease, Incidental Lewy Body Disease and Normal Elderly Subjects: Evidence Against the Body-First Hypothesis. medRxiv. 2020:2020.09.29.20204248.","DOI":"10.1101\/2020.09.29.20204248"},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm (Vienna)."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","article-title":"Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease","volume":"127","author":"Hilton","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib65","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","article-title":"Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov Disord."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","article-title":"Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients","volume":"79","author":"Stokholm","year":"2016","journal-title":"Ann Neurol."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jnen\/nlab032","article-title":"Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease","volume":"80","author":"Walker","year":"2021","journal-title":"J Neuropathol Exp Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnen\/nlaa153","article-title":"Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy","volume":"80","author":"Walker","year":"2021","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1007\/s13311-021-01146-y_bib70","first-page":"355","article-title":"Tauopathies","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handb Clin Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-019-02048-2","article-title":"Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer's disease patient brain samples","volume":"138","author":"Prokop","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","article-title":"\u201cDon't Phos Over Tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies","volume":"16","author":"Xia","year":"2021","journal-title":"Mol Neurodegener."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib73","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00259-020-04773-3","article-title":"Temporal trajectories of in vivo tau and amyloid-\u03b2 accumulation in Alzheimer's disease","volume":"47","author":"Baek","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib74","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2967\/jnumed.118.221697","article-title":"Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study","volume":"60","author":"Cho","year":"2019","journal-title":"J Nucl Med."},{"issue":"8","key":"10.1007\/s13311-021-01146-y_bib75","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry."},{"key":"10.1007\/s13311-021-01146-y_bib76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","article-title":"Tau-imaging in neurodegeneration","volume":"130","author":"Bischof","year":"2017","journal-title":"Methods."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin Transl Imaging."},{"key":"10.1007\/s13311-021-01146-y_bib78","doi-asserted-by":"crossref","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479\u201386.","DOI":"10.1212\/WNL.41.4.479"},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005072-196701000-00003","article-title":"The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia","volume":"26","author":"Gonatas","year":"1967","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib80","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/exnr.1998.7010","article-title":"Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease","volume":"156","author":"Dickson","year":"1999","journal-title":"Exp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1996.0133","article-title":"Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology","volume":"141","author":"Vickers","year":"1996","journal-title":"Exp Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib82","first-page":"871","article-title":"An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease","volume":"142","author":"Masliah","year":"1993","journal-title":"Am J Pathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-021-00464-1","article-title":"Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer's disease brains","volume":"16","author":"Sharoar","year":"2021","journal-title":"Mol Neurodegener."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer's disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib85","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuron.2016.09.016","article-title":"TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy","volume":"92","author":"Yuan","year":"2016","journal-title":"Neuron."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat Med."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib87","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol."},{"issue":"9","key":"10.1007\/s13311-021-01146-y_bib88","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib89","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer's disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med."},{"issue":"7","key":"10.1007\/s13311-021-01146-y_bib90","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib91","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series","volume":"126","author":"Kovacs","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib92","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnen\/nlw002","article-title":"Altered Proteins in the Aging Brain","volume":"75","author":"Elobeid","year":"2016","journal-title":"J Neuropathol Exp Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.24903","article-title":"Outcomes after diagnosis of mild cognitive impairment in a large autopsy series","volume":"81","author":"Abner","year":"2017","journal-title":"Ann Neurol."},{"issue":"11","key":"10.1007\/s13311-021-01146-y_bib94","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.0000000000002480","article-title":"Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies","volume":"86","author":"White","year":"2016","journal-title":"Neurology."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib95","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Spires-Jones","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib97","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology."},{"issue":"6645","key":"10.1007\/s13311-021-01146-y_bib99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib100","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am J Pathol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib102","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib103","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib104","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib106","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlx099","article-title":"The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases","volume":"77","author":"Nelson","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"issue":"7","key":"10.1007\/s13311-021-01146-y_bib107","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib108","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1750-3639.2007.00117.x","article-title":"Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient","volume":"18","author":"Leverenz","year":"2008","journal-title":"Brain Pathol."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib109","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib111","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology."},{"key":"10.1007\/s13311-021-01146-y_bib112","doi-asserted-by":"crossref","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689\u2013707; quiz 837.","DOI":"10.1002\/mds.21507"},{"issue":"Suppl 2","key":"10.1007\/s13311-021-01146-y_bib113","first-page":"S81","article-title":"Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis","volume":"64","author":"Goetz","year":"2008","journal-title":"Ann Neurol."},{"issue":"5796","key":"10.1007\/s13311-021-01146-y_bib114","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jnen\/nlw033","article-title":"\u201cNew Old Pathologies\u201d: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)","volume":"75","author":"Nelson","year":"2016","journal-title":"J Neuropathol Exp Neurol."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00401-013-1154-1","article-title":"Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease","volume":"126","author":"Nelson","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1007\/s13311-021-01146-y_bib117","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1212\/WNL.0000000000003610","article-title":"TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD","volume":"88","author":"Nag","year":"2017","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib118","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer's disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib119","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/bpa.12536","article-title":"Protein astrogliopathies in human neurodegenerative diseases and aging","volume":"27","author":"Kovacs","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1007\/s13311-021-01146-y_bib120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-444-63954-7.00028-8","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"158","author":"Mckee","year":"2018","journal-title":"Handb Clin Neurol."},{"issue":"18","key":"10.1007\/s13311-021-01146-y_bib121","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/WNL.0000000000011850","article-title":"National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome","volume":"96","author":"Katz","year":"2021","journal-title":"Neurology."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib122","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0040-1713628","article-title":"Chronic Traumatic Encephalopathy and Neuropathological Comorbidities","volume":"40","author":"Stein","year":"2020","journal-title":"Semin Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib123","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib124","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2012.02.007","article-title":"Vascular disease and dementias: paradigm shifts to drive research in new directions","volume":"9","author":"Kling","year":"2013","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib125","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3233\/JAD-2010-100603","article-title":"Prevalence and pathology of vascular dementia in the oldest-old","volume":"21","author":"Jellinger","year":"2010","journal-title":"J Alzheimers Dis."},{"issue":"Pt 9","key":"10.1007\/s13311-021-01146-y_bib126","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain."},{"issue":"5","key":"10.1007\/s13311-021-01146-y_bib127","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","article-title":"Alzheimer's disease is not \u201cbrain aging\u201d: neuropathological, genetic, and epidemiological human studies","volume":"121","author":"Nelson","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1007\/s13311-021-01146-y_bib128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease","volume":"277","author":"Snowdon","year":"1997","journal-title":"The Nun Study. JAMA."},{"issue":"8","key":"10.1007\/s13311-021-01146-y_bib129","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archneur.58.8.1243","article-title":"The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease","volume":"58","author":"Mungas","year":"2001","journal-title":"Arch Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ana.20318","article-title":"AD lesions and infarcts in demented and non-demented Japanese-American men","volume":"57","author":"Petrovitch","year":"2005","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.21142","article-title":"Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons","volume":"62","author":"Schneider","year":"2007","journal-title":"Ann Neurol."},{"issue":"14","key":"10.1007\/s13311-021-01146-y_bib132","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","article-title":"Staging and natural history of cerebrovascular pathology in dementia","volume":"78","author":"Deramecourt","year":"2012","journal-title":"Neurology."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21009","article-title":"Cognitive impact of subcortical vascular and Alzheimer's disease pathology","volume":"60","author":"Chui","year":"2006","journal-title":"Ann Neurol."},{"issue":"Suppl 1","key":"10.1007\/s13311-021-01146-y_bib134","first-page":"S397","article-title":"Selected findings from the Religious Orders Study and Rush Memory and Aging Project","volume":"33","author":"Bennett","year":"2013","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","article-title":"Brain arteriolosclerosis","volume":"141","author":"Blevins","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1007\/s13311-021-01146-y_bib136","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","article-title":"The genetic landscape of Alzheimer disease","volume":"148","author":"Carmona","year":"2018","journal-title":"Handb Clin Neurol."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib137","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib138","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, Microglia, and Neurodegenerative Diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol Med."},{"issue":"3","key":"10.1007\/s13311-021-01146-y_bib139","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci."},{"key":"10.1007\/s13311-021-01146-y_bib140","doi-asserted-by":"crossref","unstructured":"Chen Y, Colonna M. Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice? J Exp Med. 2021;218(9).","DOI":"10.1084\/jem.20202717"},{"key":"10.1007\/s13311-021-01146-y_bib141","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.pmbts.2019.10.002","article-title":"Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges?","volume":"168","author":"Prokop","year":"2019","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib142","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm0498-452","article-title":"A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1","volume":"4","author":"Crook","year":"1998","journal-title":"Nat Med."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib143","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-018-1827-x","article-title":"Integrated neurodegenerative disease autopsy diagnosis","volume":"135","author":"Lee","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib144","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1007\/s13311-021-01146-y_bib145","doi-asserted-by":"crossref","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021.","DOI":"10.1093\/neuonc\/noab106"},{"key":"10.1007\/s13311-021-01146-y_bib146","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/jpi.jpi_69_18","article-title":"Twenty Years of Digital Pathology: An Overview of the Road Travelled, What is on the Horizon, and the Emergence of Vendor-Neutral Archives","volume":"9","author":"Pantanowitz","year":"2018","journal-title":"J Pathol Inform."},{"issue":"2","key":"10.1007\/s13311-021-01146-y_bib147","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5858\/arpa.2018-0343-RA","article-title":"A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association","volume":"143","author":"Zarella","year":"2019","journal-title":"Arch Pathol Lab Med."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib148","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0463.2011.02869.x","article-title":"Virtual microscopy and digital pathology in training and education","volume":"120","author":"Hamilton","year":"2012","journal-title":"APMIS."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib149","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/s41467-019-10212-1","article-title":"Interpretable classification of Alzheimer's disease pathologies with a convolutional neural network pipeline","volume":"10","author":"Tang","year":"2019","journal-title":"Nat Commun."},{"issue":"12","key":"10.1007\/s13311-021-01146-y_bib150","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/NEN.0b013e3182768de4","article-title":"Digital pathology and image analysis for robust high-throughput quantitative assessment of Alzheimer disease neuropathologic changes","volume":"71","author":"Neltner","year":"2012","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib151","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41467-021-22399-3","article-title":"Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's disease","volume":"12","author":"Crist","year":"2021","journal-title":"Nat Commun."},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib152","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1038\/s41598-020-74917-w","article-title":"Spatial cell type composition in normal and Alzheimers human brains is revealed using integrated mouse and human single cell RNA sequencing","volume":"10","author":"Johnson","year":"2020","journal-title":"Sci Rep."},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib153","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41588-021-00875-2","article-title":"A map of transcriptional heterogeneity and regulatory variation in human microglia","volume":"53","author":"Young","year":"2021","journal-title":"Nat Genet."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib154","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","article-title":"Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease","volume":"182","author":"Chen","year":"2020","journal-title":"Cell."},{"key":"10.1007\/s13311-021-01146-y_bib155","doi-asserted-by":"crossref","unstructured":"Hampel H, Nistic\u00f2 R, Seyfried NT, Levey AI, Modeste E, Lemercier P, et al. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence. Ageing Res Rev. 2021;69:101346.","DOI":"10.1016\/j.arr.2021.101346"},{"issue":"6","key":"10.1007\/s13311-021-01146-y_bib156","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann Neurol."},{"issue":"4","key":"10.1007\/s13311-021-01146-y_bib157","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat Med."},{"key":"10.1007\/s13311-021-01146-y_bib158","doi-asserted-by":"crossref","unstructured":"Salloway S, Cummings J. Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease. Neurology. 2021.","DOI":"10.1212\/WNL.0000000000012451"},{"issue":"1","key":"10.1007\/s13311-021-01146-y_bib159","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI25410","article-title":"Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model","volume":"116","author":"Levites","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1007\/s13311-021-01146-y_bib160","doi-asserted-by":"crossref","unstructured":"Dhillon JS, Riffe C, Moore BD, Ran Y, Chakrabarty P, Golde TE, et al. A novel panel of \u03b1-synuclein antibodies reveal distinctive staining profiles in synucleinopathies. PLoS One. 2017;12(9):e0184731.","DOI":"10.1371\/journal.pone.0184731"},{"key":"10.1007\/s13311-021-01146-y_bib161","doi-asserted-by":"crossref","unstructured":"Trejo-Lopez JA, Sorrentino ZA, Riffe CJ, Lloyd GM, Labuzan SA, Dickson DW, et al. Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein. Neurosci Lett. 2020;738:135353.","DOI":"10.1016\/j.neulet.2020.135353"},{"key":"10.1007\/s13311-021-01146-y_bib162","doi-asserted-by":"crossref","unstructured":"Josephs KA et al. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study. Lancet Neurol. 2017;16(11):917-924. https:\/\/doi.org\/10.1016\/S1474-4422(17)30284-3","DOI":"10.1016\/S1474-4422(17)30284-3"},{"key":"10.1007\/s13311-021-01146-y_bib163","doi-asserted-by":"crossref","unstructured":"Josephs KA et al. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features. Ann Neurol. 2015;78(5):697-709. https:\/\/doi.org\/10.1002\/ana.24493","DOI":"10.1002\/ana.24493"},{"key":"10.1007\/s13311-021-01146-y_bib164","doi-asserted-by":"crossref","unstructured":"Kapasi, A., et al., Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology 2020;95(14):e1951-e1962. https:\/\/doi.org\/10.1212\/WNL.0000000000010454","DOI":"10.1212\/WNL.0000000000010454"},{"key":"10.1007\/s13311-021-01146-y_bib165","doi-asserted-by":"crossref","unstructured":"Nag S et al. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 2017;88(7):653-660. https:\/\/doi.org\/10.1212\/WNL.0000000000003610","DOI":"10.1212\/WNL.0000000000003610"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01146-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:36:34Z","timestamp":1761806194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1878747923001617"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01146-y","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathology of Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01146-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}